● Patient navigators took center stage at the plenary session supported by Novartis Healthcare Philippines during the Philippine National Cancer Summit 2024. Entitled “Beyond the...
Demonstrating clinically meaningful benefit in broad population of patients with early breast cancer
Ribociclib plus endocrine therapy (ET) significantly reduced the risk of disease recurrence...
The Novartis Foundation and Novartis Healthcare Philippines joined key stakeholders from around the world in pledging to foster a global partnership to stop leprosy.
The...
Sandoz Philippines and Novartis Healthcare Philippines, in partnership with the Philippine Neurological Association and Philippine Psychiatric Association, held recently a case-based discussion on how...